Please use this identifier to cite or link to this item:
|Title:||Plasma prolactin and fluphenazine concentrations in patients receiving fluphenazine decanoate: stability over injection intervals.||Austin Authors:||Norman, Trevor R ;Marriott, P F;Kimber, N M;Burrows, Graham D||Affiliation:||Department of Psychiatry, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia||Issue Date:||1-Oct-1987||Publication information:||International Clinical Psychopharmacology; 2(4): 299-305||Abstract:||Plasma prolactin and fluphenazine concentrations were measured in a group of 17 patients (9 males, 8 females) with schizophrenia who were receiving chronic treatment with fluphenazine decanoate. Neither measure was significantly correlated with clinical effect, as measured by the Brief Psychiatric Rating Scale, at any of the 5 pre-injection times examined. None of the measures showed statistically significant (P greater than 0.05; MANOVA) variations with time. Neither measure showed a significant correlation with the dose (expressed as mg/kg) of fluphenazine. The implications of the study for monitoring chronic treatment of schizophrenia are discussed.||Gov't Doc #:||3693869||URI:||http://ahro.austin.org.au/austinjspui/handle/1/13005||URL:||https://pubmed.ncbi.nlm.nih.gov/3693869||Type:||Journal Article||Subjects:||Adult
Fluphenazine.analogs & derivatives.blood.therapeutic use
|Appears in Collections:||Journal articles|
Show full item record
checked on Nov 25, 2022
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.